
Panel Discussion on 'The next decade of injectables: Science, scale and new therapies' | #InjectableInnovationsConclave 2026 | 10th April 2026 | Hyderabad | Presented by Adam Fabriwerk and Powered by OPTIMA packaging group Moderated by Ms Viveka Roychowdhury, Editor, #ExpressPharma
Panellists:
+ Mr Ankur Shah, Founder & Chairman, Invengene Private Limited
+ Mr Atul Shastri, President - Global Operations, Eugia Pharma Specialities Ltd
+ Mr RAJA BHANU, DG, Pharmexcil (Pharmaceuticals Export Promotion Council of India)
[1] Early collaboration and globally scalable product design are becoming critical to de-risk investments and secure long-term partnerships.
[2] Success in injectables will depend on the ability to take products from the bench to the floor. We need to integrate manufacturing complexity and supply chain considerations from the very start.
[3] India builds world-class plants but not equivalent R&D ecosystems. The gap between lab and large-scale production is where compliance and sterility challenges emerge.
[4] AI, ML, and IoT can reduce human error, ensure sterility (a binary outcome), and significantly compress timelines — positioning India to lead in next-gen injectable innovation.
[5] While India advances in affordability, scale, and AI-driven innovation, human expertise remains central, and self-reliance must be built to withstand geopolitical risks.
[6] Amid rising geopolitical tensions, building self-reliance through strong domestic networks is critical to prevent supply disruptions, and while this transition will take time, the groundwork must begin immediately.
Vishal Wagh | Lakshmipriya Nair | Kalyani Sharma | Neha Aathavale | Swati Rana | Rajesh Bhatkal | Ashish Rampure | Aachal Jamshetkar | John P K | Amruta Shinde | Nilesh Mungekar | Lata Randive | Rajani verma | Mahendra P @DoC_GoI



English
































